Quick Answer
Ovid Therapeutics Inc. reported Total Assets of $150.93 million for fiscal year 2025.
Ovid Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $150.93M | +63.8% |
| 2024 | $92.17M | -36.0% |
| 2023 | $144.03M | -7.2% |
| 2022 | $155.27M | -20.2% |
| 2021 | $194.54M | +156.2% |
| 2020 | $75.93M | -6.1% |
| 2019 | $80.84M | +69.7% |
| 2018 | $47.65M | -46.7% |
| 2017 | $89.46M | +68.7% |
| 2016 | $53.03M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $63.85M | -37.8% | -17.5% |
| June 30, 2025 | $77.43M | -34.4% | -5.2% |
| March 31, 2025 | $81.65M | -38.0% | -11.4% |
| December 31, 2024 | $92.17M | -36.0% | -10.2% |
| September 30, 2024 | $102.65M | -17.9% | -13.1% |
| June 30, 2024 | $118.09M | -13.3% | -10.3% |
| March 31, 2024 | $131.61M | -8.2% | -8.6% |
| December 31, 2023 | $144.03M | -7.2% | +15.2% |
- Ovid Therapeutics Inc. showed an increase of +63.8% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Ovid Therapeutics Inc.’s total assets has grown by 184.6% (from $53.03 million to $150.93 million).
- The most recent figure is from Ovid Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: